» Articles » PMID: 26473627

AB-Bind: Antibody Binding Mutational Database for Computational Affinity Predictions

Overview
Journal Protein Sci
Specialty Biochemistry
Date 2015 Oct 17
PMID 26473627
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Antibodies (Abs) are a crucial component of the immune system and are often used as diagnostic and therapeutic agents. The need for high-affinity and high-specificity antibodies in research and medicine is driving the development of computational tools for accelerating antibody design and discovery. We report a diverse set of antibody binding data with accompanying structures that can be used to evaluate methods for modeling antibody interactions. Our Antibody-Bind (AB-Bind) database includes 1101 mutants with experimentally determined changes in binding free energies (ΔΔG) across 32 complexes. Using the AB-Bind data set, we evaluated the performance of protein scoring potentials in their ability to predict changes in binding free energies upon mutagenesis. Numerical correlations between computed and observed ΔΔG values were low (r = 0.16-0.45), but the potentials exhibited predictive power for classifying variants as improved vs weakened binders. Performance was evaluated using the area under the curve (AUC) for receiver operator characteristic (ROC) curves; the highest AUC values for 527 mutants with |ΔΔG| > 1.0 kcal/mol were 0.81, 0.87, and 0.88 using STATIUM, FoldX, and Discovery Studio scoring potentials, respectively. Some methods could also enrich for variants with improved binding affinity; FoldX and Discovery Studio were able to correctly rank 42% and 30%, respectively, of the 80 most improved binders (those with ΔΔG < -1.0 kcal/mol) in the top 5% of the database. This modest predictive performance has value but demonstrates the continuing need to develop and improve protein energy functions for affinity prediction.

Citing Articles

Decoding the effects of mutation on protein interactions using machine learning.

Xu W, Li A, Zhao Y, Peng Y Biophys Rev (Melville). 2025; 6(1):011307.

PMID: 40013003 PMC: 11857871. DOI: 10.1063/5.0249920.


Identification and Validation of B-Cell Epitopes on the VP1 Protein of Parvovirus B19 through Molecular Docking and Dynamics Simulation.

Kuruvilla Thomas R, Balasundaram A, Fathima G, Sankar S, Davis G D, Ramamoorthy M ACS Omega. 2025; 10(4):3598-3609.

PMID: 39926541 PMC: 11799995. DOI: 10.1021/acsomega.4c08353.


Amino Acids Frequency and Interaction Trends: Comprehensive Analysis of Experimentally Validated Viral Antigen-Antibody Complexes.

Pais R, Nagraj A, Patel R, Gavade A, Momin M, Scheele J Mol Biotechnol. 2025; .

PMID: 39775710 DOI: 10.1007/s12033-024-01361-w.


PPB-Affinity: Protein-Protein Binding Affinity dataset for AI-based protein drug discovery.

Liu H, Chen P, Zhai X, Huo K, Zhou S, Han L Sci Data. 2024; 11(1):1316.

PMID: 39627219 PMC: 11615212. DOI: 10.1038/s41597-024-03997-4.


Graph masked self-distillation learning for prediction of mutation impact on protein-protein interactions.

Zhang Y, Dong M, Deng J, Wu J, Zhao Q, Gao X Commun Biol. 2024; 7(1):1400.

PMID: 39462102 PMC: 11513059. DOI: 10.1038/s42003-024-07066-9.


References
1.
Carter P . Potent antibody therapeutics by design. Nat Rev Immunol. 2006; 6(5):343-57. DOI: 10.1038/nri1837. View

2.
Kortemme T, Baker D . Computational design of protein-protein interactions. Curr Opin Chem Biol. 2004; 8(1):91-7. DOI: 10.1016/j.cbpa.2003.12.008. View

3.
Chothia C, Lesk A . Canonical structures for the hypervariable regions of immunoglobulins. J Mol Biol. 1987; 196(4):901-17. DOI: 10.1016/0022-2836(87)90412-8. View

4.
Verdonk M, Berdini V, Hartshorn M, Mooij W, Murray C, Taylor R . Virtual screening using protein-ligand docking: avoiding artificial enrichment. J Chem Inf Comput Sci. 2004; 44(3):793-806. DOI: 10.1021/ci034289q. View

5.
Wang L, Deng Y, Knight J, Wu Y, Kim B, Sherman W . Modeling Local Structural Rearrangements Using FEP/REST: Application to Relative Binding Affinity Predictions of CDK2 Inhibitors. J Chem Theory Comput. 2015; 9(2):1282-93. DOI: 10.1021/ct300911a. View